
Notably, AstraZeneca established a rare disease business unit in China in September 2021.
According to GlobalData Market Size and Growth Analytics tool, the reproductive health devices market is forecast to grow at a…
For breast and thyroid tissues, See-Mode provides a classification of lesions in clinical images as per BI-RADS and TI-RADS rating…
According to the data and analytics company, the company has recently marked the first phase of the commissioning of its…
While the obesity market is projected to grow strongly in the forecast period, the potential barriers to this growth include…
According to GlobalData, the primary driver of the suturing devices market is the increasing number of surgical procedures, especially those…
According to GlobalData, the revolutionary technology is coming faster than most people in the industry currently recognize.
According to GlobalData’s Pharma Intelligence Center, over the past year, Dr. Reddy’s has been involved in five deals related to…
According to GlobalData’s study of companies’ annual reports and earnings call transcripts in 2022, despite the ongoing volatile market conditions…
The adaptability of these rapid testing devices will likely benefit them not only in COVID-19 tests but in the overall…
The typical age for when colorectal cancer screening begins is around 50, at which point patients undergo either routine colonoscopy…
Lilly will likely maintain or increase its market share in the basal insulin space as the average out-of-pocket cost for…
Currently, GSK, AstraZeneca, Roche, and Aurinia Pharmaceuticals are the key players in the lupus marketplace, and GlobalData anticipates all four…
Psilocybin is naturally derived from psilocybin mushrooms, predominantly the magic mushroom, Psilocybe cubensis, while psilocin is the pharmacologically active metabolite…
GlobalData observed around 5% growth in the robotic accessories market from 2021 to 2022, compared with 30% growth from 2020…
GlobalData analysis reveals that alongside the recent development of ICD RPM devices, subcutaneous ICDs have been aggressively gaining market share…
Despite numerous policy interventions to curb obesity’s prevalence, the condition continues to rise across the 7MM.
According to GlobalData, Waylivra (volanesorsen) is another apoCII inhibitor marketed by Ionis in the EU for patients with FCS with…